Flexible pressure delivery modification of continuous positive airway pressure for obstructive sleep apnea does not improve compliance with therapy: systematic review and meta-analysis.
As a result, particle surface and internal porosity have been designed to meet criteria‐facilitating passive targeting (e.g., for pulmonary delivery), modification of the drug release profile (e.g., attenuation of the burst release) and active targeting via ligand binding to specific cell receptors.
This review details recent examples of engineered knottin peptides; their use as molecular imaging agents, therapeutics, and drug delivery vehicles; modifications that can be introduced to improve peptide folding and bioactivity; and future perspectives and challenges in the field.
These include altering service delivery with modifications of routine practice, such as giving patients' with language needs more time, or seeking collaboration with social services that would be able to assist in legal and/or social issues.
We describe what Care Groups are, the key ingredients (the "secret sauce") that seem to be important for their successful implementation, their history, the field experience with use of this delivery strategy, modifications that are emerging in Care Group implementation, and how Care Groups might be integrated into government health programs.
By overcoming the challenges to be used in therapeutic delivery, the modification of GBNs in biological systems spurs up further developments in biomedical applications.
The chapters in this book include a look at a range of biomaterials including hydrogels and other matrices (natural, synthetic, self-healing) for various applications including drug and gene delivery, surface modification and functionalization of biomaterials.
Structured biofilm colonies (BR-F and BR-RF) both up-regulate and down-regulate distinct genes involved in cell wall remodeling as well as genes involved in the delivery and modification of secreted and cell wall/membrane-attached proteins.
The disparity between the high percentage of homes with water treatment products and the lower percentage of homes with detectable chlorine in stored drinking water suggested that the communication strategy that accompanied product delivery needed modification.
The BE WELL intervention clearly differs from the delivery of lifestyle modifications in the usual primary care setting.
